Innovation is generally understood as the process of bringing valuable new products (and services) to market, and has been highlighted as one of the key factors that determines the future success of an organisation.
Intellectual property (IP), and the management of the IP throughout the new product development process is a critical factor in successfully commercialising products and services.
Click here to register.
The purpose of this webinar is to briefly outline what forms of IP protection may be required at each stage of the product development process, and how overall management of the IP may lead to overall improved revenues and profitability.
8/06/21 from 3:00 PM to 4:00 PM |
Relator: Maria Coro PLA Gutierrez and Sebastian Hanck
EUIPO - The European Union Intellectual Property Office
Maria Coro PLA Gutierrez, IP Expert in the Customer Department, EUIPO, has been working in the world of Intellectual Property for more than 30 years. She started as a patent examiner (mechanical specialty) at the Spanish Patent and Trademark Office (OEPM), specifically in the Technological Information Department where, in addition to making patent reports, she collaborated in the creation of several Technology Watch Bulletins. In 2013 she joined the Management Support Unit of the OEPM and was in charge of the SME Support Service for 6 years. In 2019 she was assigned to the European Union Intellectual Property Office (EUIPO) as Seconded National Exper. Since then, she has been working in the Customer Department, working mainly in the SME Program of this office.
Sebastian Hanck, Team Leader, Supportive Instrument in the Customer Department, EUIPO, Belgian, joined the EUIPO in 1997, worked in the Operations Department as trademarks examiner and then as Head of examination sector for 15 years. He then joined the Customer department where he was in charge of managing the Key User Programme (EUIPO key account programme for big customers) and now, since January 2021, leads the team SME supportive initiatives which includes the SME Fund and others.